Cheng; Alan C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cheng; Alan C..The latest application filed is for "high affinity antibodies targeting tau phosphorylated at serine 413".

Company Profile

5.21.24

Cheng; Alan C. - San Francisco CA
Cheng; Alan C. - Cambridge MA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds that inhibit MCL-1 protein Grant 11,306,107 - Brown , et al. April 19, 2	2022-04-19
High Affinity Antibodies Targeting Tau Phosphorylated At Serine 413 App 20210403541 - Baker; Jeanne E. ; et al.	2021-12-30
Compounds That Inhibit Mcl-1 Protein App 20210230189 - BROWN; Sean P. ; et al.	2021-07-29
Heteroaryl-substituted triazoles as APJ receptor agonists Grant 11,046,680 - Chen , et al. June 29, 2	2021-06-29
Triazole furan compounds as agonists of the APJ receptor Grant 10,736,883 - Brown , et al. A	2020-08-11
Triazole pyridyl compounds as agonists of the APJ receptor Grant 10,689,367 - Chen , et al.	2020-06-23
Triazole Pyridyl Compounds As Agonists Of The Apj Receptor App 20190300507 - CHEN; Yinhong ; et al.	2019-10-03
Triazole Furan Compounds As Agonists Of The Apj Receptor App 20190275008 - BROWN; Matthew ; et al.	2019-09-12
Triazole agonists of the APJ receptor Grant 10,221,162 - Chen , et al.	2019-03-05
Compounds for use in preparing heterocyclic triazole agonists of the APJ receptor Grant 10,150,760 - Chen , et al. Dec	2018-12-11
Triazole Agonists Of The Apj Receptor App 20180319773 - CHEN; Ning ; et al.	2018-11-08
Compounds For Use In Preparing Heterocyclic Triazole Agonists Of The Apj Receptor App 20180222895 - Chen; Xiaoqi ; et al.	2018-08-09
Heterocyclic triazole compounds as agonists of the APJ receptor Grant 9,988,369 - Chen , et al. June 5, 2	2018-06-05
Triazole agonists of the APJ receptor Grant 9,868,721 - Chen , et al. January 16, 2	2018-01-16
Intermediates for preparing triazole agonists of the APJ receptor Grant 9,845,310 - Chen , et al. December 19, 2	2017-12-19
Heterocyclic Triazole Compounds As Agonists Of The Apj Receptor App 20170320860 - CHEN; Xiaoqi ; et al.	2017-11-09
Triazole agonists of the APJ receptor Grant 9,745,286 - Chen , et al. August 29, 2	2017-08-29
Triazole agonists of the APJ receptor Grant 9,656,997 - Chen , et al. May 23, 2	2017-05-23
Triazole agonists of the APJ receptor Grant 9,573,936 - Chen , et al. February 21, 2	2017-02-21
Triazole Agonists Of The Apj Receptor App 20170042872 - CHEN; Ning ; et al.	2017-02-16
Triazole Agonists Of The Apj Receptor App 20170042897 - Chen; Ning ; et al.	2017-02-16
Triazole Agonists Of The Apj Receptor App 20170044131 - CHEN; Ning ; et al.	2017-02-16
Triazole Agonists Of The Apj Receptor App 20170042871 - Chen; Ning ; et al.	2017-02-16
Triazole Agonists Of The Apj Receptor App 20170035744 - CHEN; Ning ; et al.	2017-02-09
Triazole Agonists Of The Apj Receptor App 20170037026 - CHEN; Ning ; et al.	2017-02-09
Triazole Agonists Of The Apj Receptor App 20160340336 - Chen; Ning ; et al.	2016-11-24
Benzimidazole And Azabenzimidazole Compounds That Inhibit Anaplastic Lymphoma Kinase App 20160046625 - Boezio; Christiane M. ; et al.	2016-02-18
Benzimidazole and azabenzimidazole compounds that inhibit anaplastic lymphoma kinase Grant 9,115,127 - Boezio , et al. August 25, 2	2015-08-25
Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of use Grant 8,883,782 - Cheng , et al. November 11, 2	2014-11-11
Pyrimidine compounds that inhibit anaplastic lymphoma kinase Grant 8,716,281 - Bryan , et al. May 6, 2	2014-05-06
Benzimidazole And Azabenzimidazole Compounds That Inhibit Anaplastic Lymphoma Kinase App 20130217668 - Boezio; Christiane M. ; et al.	2013-08-22
Pyrimidine Compounds That Inhibit Anaplastic Lymphoma Kinase App 20130158019 - Bryan; Marian C. ; et al.	2013-06-20
Spiro-tricyclic ring compounds as beta-secretase modulators and methods of use Grant 8,426,447 - White , et al. April 23, 2	2013-04-23
Nitrogen-containing heterocyclyl ketones and methods of use Grant 8,314,087 - Albrecht , et al. November 20, 2	2012-11-20
Heteroaryl Compounds as PIKK Inhibitors App 20120190666 - Bode; Christiane ; et al.	2012-07-26
Indole/Benzimidazole Compounds as mTOR Kinase Inhibitors App 20120165334 - Boezio; Alessandro ; et al.	2012-06-28
Spiro-tetracyclic Ring Compounds As Beta-secretase Modulators And Methods Of Use App 20110251190 - CHENG; Yuan ; et al.	2011-10-13
Spiro-tricyclic Ring Compounds As Beta-secretase Modulators And Methods Of Use App 20100087429 - White; Ryan ; et al.	2010-04-08
Nitrogen-Containing heterocyclyl ketones and methods of use App 20080280917 - Albrecht; Brian K. ; et al.	2008-11-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.